Andrew Obenshain insider trades
Open-market stock purchases and sales by Andrew Obenshain, President and CEO at bluebird bio, Inc, from SEC Form 4 filings since Feb 2, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BLUE bluebird bio, Inc: 23 sales, last Jun 2, 2025